TCM Constitution, Pattern Types, and Disease Factors in Primary Lung Cancer.

Launched by CHINA MEDICAL UNIVERSITY HOSPITAL · Nov 16, 2023

Keywords

ClinConnect Summary

This clinical trial is studying how Traditional Chinese Medicine (TCM) can help understand and treat primary lung cancer in patients in Taiwan. The researchers want to explore the relationships between different TCM concepts—like body constitution and pattern identification—and how these may relate to the progression of lung cancer. They hope this study will provide valuable insights into the characteristics of lung cancer from a TCM perspective.

To participate in this study, individuals must be diagnosed with primary lung cancer, be between 18 and 100 years old, and agree to join after being fully informed about the trial. They will be asked to provide information about their health, lifestyle, and symptoms through surveys. The study will run from November 2023 to May 2025, and participants can expect to be interviewed by doctors in a hospital setting. It's important to note that those with certain health conditions or who have received previous cancer treatments may not be eligible to participate.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients diagnosed with primary lung cancer.
• • Age greater than 18 years and less than 100 years.
• • After explanation, they agree to join this study and voluntarily sign the subject consent form, and can understand the content of the questionnaire.
• Exclusion Criteria:
• • Pregnant women.
• • Severe mental illness that affects the response to the questionnaire.
• • Has been treated (e.g., surgery, chemotherapy, targeted therapy, immunotherapy, radiation therapy, etc.).
• • Concomitant with other uncured primary malignancies.
• • Patients with other serious primary diseases (such as: liver and kidney dysfunction, hematolymphatic system diseases, etc.).
• • Severe respiratory diseases that are not lung cancer (e.g. primary emphysema, interstitial fibrosis, etc.) .